Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Efficacy Study of GSK Biologicals' Quadrivalent Influenza Vaccine GSK2321138A (FLU D-QIV) When Administered in Children

NCT01439360 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01439360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01439360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Efficacy Study of GSK Biologicals' Quadrivalent Influenza Vaccine GSK2321138A (FLU D-QIV) When Administered in Children
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2011
Completion date
December 31, 2014
Enrollment
12,046 (actual)
Sites
103

Conditions

As the registry lists them; a condition with its own page is linked.

influenza